Detailed information for compound 1996268

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 342.361 | Formula: C15H16F2N2O3S
  • H donors: 1 H acceptors: 3 LogP: 2.63 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: FC(COc1cc(ccc1c1cnccc1C)NS(=O)(=O)C)F
  • InChi: 1S/C15H16F2N2O3S/c1-10-5-6-18-8-13(10)12-4-3-11(19-23(2,20)21)7-14(12)22-9-15(16)17/h3-8,15,19H,9H2,1-2H3
  • InChiKey: SNRWNQXAUHGQCA-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cytochrome P450, family 17, subfamily A, polypeptide 1 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Cytochrome P450 family protein cytochrome P450, family 17, subfamily A, polypeptide 1 508 aa 468 aa 25.2 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Onchocerca volvulus 0.0017 0 0.5
Toxoplasma gondii phosphotransferase enzyme family protein 0.0179 1 1
Trypanosoma brucei choline kinase 0.0017 0 0.5
Schistosoma mansoni choline/ethanolamine kinase 0.0017 0 0.5
Schistosoma mansoni choline/ethanolamine kinase 0.0017 0 0.5
Trichomonas vaginalis choline/ethanolamine kinase, putative 0.0017 0 0.5
Entamoeba histolytica choline/ethanolamine kinase, putative 0.0017 0 0.5
Trypanosoma cruzi choline kinase 0.0017 0 0.5
Echinococcus granulosus choline:ethanolamine kinase 0.0179 1 1
Trypanosoma cruzi choline ethanolamine kinase, putative 0.0017 0 0.5
Loa Loa (eye worm) choline/ethanolamine kinase 0.0179 1 1
Giardia lamblia Ethanolamine kinase, putative 0.0017 0 0.5
Echinococcus multilocularis choline:ethanolamine kinase 0.0179 1 1
Plasmodium vivax choline kinase, putative 0.0179 1 1
Trypanosoma brucei choline/ethanolamine kinase 0.0017 0 0.5
Leishmania major choline/ethanolamine kinase, putative 0.0017 0 0.5
Entamoeba histolytica choline/ethanolamine kinase, putative 0.0017 0 0.5
Onchocerca volvulus Putative choline\/ethanolamine kinase 0.0017 0 0.5
Schistosoma mansoni choline kinase 0.0017 0 0.5
Leishmania major choline kinase 0.0017 0 0.5
Plasmodium falciparum choline kinase 0.0179 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 32 nM BindingDB_Patents: Total SPA Assay. The assays were performed in U-bottom 384-well optiplates. The final assay volume was 15 ul prepared from 7.5 ul additions of microsomes (prepared as a high-speed pellet from homogenized HEK2 cells stably transfected with CYP17), substrates (3H-Pregnenolone and NADPH) and test compounds in assay buffer (50 mM Potassium phosphate pH 7.2, 10% glycerol). The reaction was initiated by the combination of the microsomes and substrates in wells containing compound. The reaction was incubated at room temperature for 45 minutes and terminated by adding 7.5 ul of 0.2N HCl to each well. Following an incubation period of 10 minutes, anti-DHEA-coated SPA beads were added to the terminated reaction. The plate was sealed and incubated overnight with shaking at 4 C. The beads were allowed to settle in the plate for 1 hour and the plate read on a TOPCOUNT (Perkin-Elmer) plate reader.Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.